Pharma BD Deal Intelligence

OSI Pharmaceuticals, Inc. / Eyetech Pharmaceuticals, Inc.

2005 · Acquisition/Merger · $935M · Complete

Announcement Sentiment
25
Negative

OSI agrees to acquire Eyetech for ~$935M cash+stock ($20/share, 43% premium). Gains Macugen (wet AMD). Closed Nov 14, 2005.

Key facts

See the full interactive analysis, sources & comparables →